These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 9571226
1. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. Prakash C, Cui D, Baxter JG, Bright GM, Miceli J, Wilner K. Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226 [Abstract] [Full Text] [Related]
2. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C, Cui D. Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [Abstract] [Full Text] [Related]
3. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C, Soliman V. Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [Abstract] [Full Text] [Related]
4. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy. Colizza K, Awad M, Kamel A. Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832 [Abstract] [Full Text] [Related]
8. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans. Vermeir M, Naessens I, Remmerie B, Mannens G, Hendrickx J, Sterkens P, Talluri K, Boom S, Eerdekens M, van Osselaer N, Cleton A. Drug Metab Dispos; 2008 Apr; 36(4):769-79. PubMed ID: 18227146 [Abstract] [Full Text] [Related]
15. Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans. Karanam B, Madeira M, Bradley S, Wenning L, Desai R, Soli E, Schenk D, Jones A, Dean B, Doss G, Garrett G, Crumley T, Nirula A, Lai E. Drug Metab Dispos; 2007 Jul; 35(7):1196-202. PubMed ID: 17431030 [Abstract] [Full Text] [Related]
16. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C, Cui D, Potchoiba MJ, Butler T. Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [Abstract] [Full Text] [Related]
17. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C, Schwarz T, Kubitza D, Mueck W, Lang D. Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845 [Abstract] [Full Text] [Related]
18. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W. Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243 [Abstract] [Full Text] [Related]
19. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys. Tan EY, Hartmann G, Chen Q, Pereira A, Bradley S, Doss G, Zhang AS, Ho JZ, Braun MP, Dean DC, Tang W, Kumar S. Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052 [Abstract] [Full Text] [Related]